AstraZeneca Wants Scope Narrowed In Seroquel MDL

Law360, New York (July 15, 2009, 12:00 AM EDT) -- AstraZeneca LP is demanding that the judge overseeing the product liability litigation involving Seroquel limit further fact discovery to just the diabetes injury claims, arguing that the plaintiffs have had plenty of time to pursue discovery related to other injuries purportedly caused by the antipsychotic drug.

On Tuesday, AstraZeneca filed a motion to preclude additional fact discovery on general issues relating to alleged injuries other than diabetes, arguing that plaintiffs should be required to stick to their original claim that general fact discovery had been completed...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.